(120 days)
Not Found
No
The device description mentions using CT-scan data to design the plates based on an average anatomical model, but there is no indication of AI or ML being used for analysis, diagnosis, or treatment. The design process appears to be based on statistical averaging of anatomical data.
Yes
The device is intended for the reconstructive treatment of trauma and bone excision, which aligns with the definition of a therapeutic device.
No
The device is described as an implant system used for reconstruction of orbital floor and/or medial wall trauma or bone excision. It is a treatment device, not one that identifies or diagnoses a condition.
No
The device description explicitly states that the system comprises physical components: a pre-bent titanium orbital floor implant, a globe retractor, and plate-holding forceps.
Based on the provided information, the Stryker Universal Orbital Floor System is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use is for the reconstruction of the orbital floor and/or medial wall. This is a surgical procedure involving the implantation of a device, not a diagnostic test performed in vitro (outside the body) on biological samples.
- Device Description: The device is a physical implant (pre-bent titanium plate), a surgical tool (globe retractor), and another surgical tool (plate-holding forceps). These are instruments used during surgery, not reagents, kits, or instruments used to analyze biological samples for diagnostic purposes.
- Lack of Diagnostic Function: The device does not perform any analysis of biological samples (like blood, urine, tissue, etc.) to provide information about a patient's health status, disease, or condition. Its function is purely reconstructive.
IVD devices are specifically designed to be used in vitro to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Stryker Universal Orbital Floor System does not fit this definition.
N/A
Intended Use / Indications for Use
The Stryker Universal Orbital Floor System is intended to be used in the reconstruction of the floor and/or medial wall of the orbit.
The Stryker Universal Orbital Floor System is indicated for the reconstructive treatment of orbital floor and/or medial wall trauma or bone excision in adult patients.
Product codes (comma separated list FDA assigned to the subject device)
JEY - Bone Plate
Device Description
The Stryker Universal Orbital Floor System comprises a pre-bent titanium orbital floor implant that approximates the shape and dimensions of the average normal orbital floor and medial wall (in order to facilitate the operative goal of restoring normal (pretraumatic) orbital volume as accurately as possible), a globe retractor for retraction of the orbital contents off the orbital floor and walls (in order to provide exposure of the fracture site(s)), and a plate-holding forceps (that facilitates the insertion and positioning of the plate within the orbit).
The plates are designed based on an average anatomical model of CT-scan data taken from 300 subjects (92% Caucasian). The metadata of the 300 subjects that have been included in the generation of the average anatomical model is listed in table 1. The selected scans were obtained from healthy subjects without any deformation of the bony orbital structures.
The implant is provided in pre-bent left and right and in small and large sizes. A medial wall extension is attached to the floor section of the implant in order to provide coverage for a co-extensive medial wall fracture. If not needed, this medial wall extension may be removed by cutting through the designated cutting lines on the implant. The implant is fixed to the infra-orbital rim via either the holes on the provided fixation arms or through the anterior screw holes on the plate itself.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT-scan data
Anatomical Site
floor and/or medial wall of the orbit
Indicated Patient Age Range
adult patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical Testing:
No clinical testing was performed to support this submission.
Non-Clinical Testing:
The Stryker Universal Orbital Floor System was subjected to Verification and Validation testing of biocompatibility, cleaning, sterilization, corrosion resistance, stability of plate. functionality over lifetime, transportation of the complete set and of packaging, an end product test and a design validation - end user test. The System passed all tests.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.4760 Bone plate.
(a)
Identification. A bone plate is a metal device intended to stabilize fractured bone structures in the oral cavity. The bone segments are attached to the plate with screws to prevent movement of the segments.(b)
Classification. Class II.
0
stryker®
| 510(k) Summary | APR 0 9 2013 | |
|---|---|---|
| Date prepared: | December 6, 2012 | |
| Submitter: | Stryker Leibinger GmbH & Co. KG | |
| Bötzinger Straße 41 | ||
| 79111 Freiburg. | ||
| Germany | ||
| Contact: | Jamshed Badarpura | |
| Phone: (269) 389-4260 | ||
| jamshed.badarpura@stryker.com | ||
| Stryker Craniomaxillofacial | ||
| 750 Trade Center Way | ||
| Portage, MI 49002 | ||
| USA | ||
| Proprietary Name: | Stryker Universal Orbital Floor System | |
| Common Name: | Universal Orbital Floor | |
| Proposed Regulatory Class: | Class II | |
| Product Codes: | JEY - Bone Plate | |
| Predicate Device: | Synthes Craniofacial Plate and Screw System - | |
| K080331 |
Intended Use:
The Stryker Universal Orbital Floor System is intended to be used in the reconstruction of the floor and/or medial wall of the orbit.
Indication for Use:
The Stryker Universal Orbital Floor System is indicated for the reconstructive treatment of orbital floor and/or medial wall trauma or bone excision in adult patients.
Device Description:
The Stryker Universal Orbital Floor System comprises a pre-bent titanium orbital floor implant that approximates the shape and dimensions of the average normal orbital floor and medial wall (in order to facilitate the operative goal of restoring normal (pretraumatic) orbital volume as accurately as possible), a globe retractor for retraction of
Traditional 510(k)
Page 2 of 6
1
stryker®
the orbital contents off the orbital floor and walls (in order to provide exposure of the fracture site(s)), and a plate-holding forceps (that facilitates the insertion and positioning of the plate within the orbit).
The plates are designed based on an average anatomical model of CT-scan data taken from 300 subjects (92% Caucasian). The metadata of the 300 subjects that have been included in the generation of the average anatomical model is listed in table 1. The selected scans were obtained from healthy subjects without any deformation of the bony orbital structures.
Table 1: Meta data of the 300 CT scans
Image /page/1/Figure/5 description: This image shows a table of data organized by age, gender, and ethnic group. The age ranges are in increments of 10 years, from 10-19 to 90-99. For the age range of 10-19, there are 18 people, 122 females, and 276 people in the 'ca' ethnic group. The average age is 59 years.
Gender: 122 female (f) and 178 male (m);
Ethnic Group: 276 Caucasians (ca), 3 Middle-East (me), 21 unknown (xx)
The implant is provided in pre-bent left and right and in small and large sizes. A medial wall extension is attached to the floor section of the implant in order to provide coverage for a co-extensive medial wall fracture. If not needed, this medial wall extension may be removed by cutting through the designated cutting lines on the implant. The implant is fixed to the infra-orbital rim via either the holes on the provided fixation arms or through the anterior screw holes on the plate itself.
Clinical Testing:
No clinical testing was performed to support this submission.
Non-Clinical Testing:
The Stryker Universal Orbital Floor System was subjected to Verification and Validation testing of biocompatibility, cleaning, sterilization, corrosion resistance, stability of plate.
Traditional 510(k)
2
stryker®
functionality over lifetime, transportation of the complete set and of packaging, an end product test and a design validation - end user test. The System passed all tests.
Comparison to Predicate Device
The Stryker Universal Orbital Floor System ("Subject Device") is compared to its Predicate Device for Substantial Equivalence. Side-by-side comparison tables summarizing the following criteria are provided below: .
- Intended Use A:
- B: Principle of Operation
- Technological Characteristics ்.
- D: Packaging
A: Indications for Use
Table 1: Substantial Equivalence of Indications for Use
| Subject Device | Predicate Device | |
|---|---|---|
| Intended Use: | ||
| The Stryker Universal Orbital Floor | ||
| System is intended to be used in the | ||
| reconstruction of the floor and/or | ||
| medial wall of the orbit. | Intended Use / Indications for Use: | |
| The Synthes Craniofacial Plate and Screw | ||
| System is intended for use in selective trauma | ||
| of the midface and craniofacial skeleton, | ||
| craniofacial surgery, reconstructive procedures | ||
| and selective orthognathic surgery of the | ||
| maxilla and chin. | ||
| Intended Use | Indications for Use: | |
| The Stryker Universal Orbital Floor | ||
| System is indicated for the | ||
| reconstructive treatment of orbital | ||
| floor and/or medial wall trauma or | ||
| bone excision in adult patients. | Indications | |
| Synthes MatrixMIDFACE Preformed Orbital | ||
| Plates are intended for trauma repair and | ||
| reconstruction of the craniofacial skeleton. |
- Orbital floor fractures
- Medial orbital wall fractures
– Combined orbital floor and medial wall
fractures |
The intended use of the Subject Device is included in the intended use of the Predicate Device. The Predicate has the same indications for use as the Subject Device, though without age specification.
3
B: Principle of Operation
Table 2: Substantial Equivalence of Principle of Operation
| Subject Device | Predicate Device | |
|---|---|---|
| Application | ||
| Area | CMF/Orbital | CMF/Orbital |
| Operational | ||
| principle | Reconstruct the orbital floor and/or | |
| medial wall | Reconstruct the orbital floor and/or medial wall | |
| Mode of | ||
| fixation | Plate fixation with screws inserted | |
| through dedicated screw holes. | Plate fixation with screws inserted through | |
| dedicated screw holes. | ||
| Duration of | ||
| implantation | ||
| within the body | Permanent implant | Permanent implant |
The basic operational principle of the Subject Device, as well as the Predicate Device, is to reconstruct the orbital floor and/or medial wall. The fixation method of both the Subject Device and the Predicate is with screws inserted through dedicated screw holes. The Subject Device and the Predicate Device are both permanent implants.
C: Technological Characteristics
Table 3: Substantial Equivalence of Technological Characteristics
| Subject Device | Predicate Device | |
|---|---|---|
| Material | Commercially Pure Titanium | Pure Titanium |
| Design | 3D pre-bent plate based on average | |
| anatomical model; 0.4mm thickness; | ||
| Based on average anatomical model of | ||
| 300 CT-scans and comprising 276 | ||
| Caucasian subjects (92%) | 3D pre-bent plate based on average | |
| anatomical model; 0.4mm thickness | ||
| Based on average anatomical model of 279 | ||
| Caucasian CT-scans | ||
| Mode of | ||
| Modification | Cutting / trimming along dedicated | |
| lines; pliable mesh structure for | ||
| bending | Cutting / trimming along dedicated lines; | |
| pliable mesh structure for bending | ||
| Sizes | 2 sizes: large and small for left and | |
| right each | 2 sizes: large and small for left and right each | |
| Dimensions | Large Plate: | |
| L=35mm, W=36mm, H=16mm | ||
| Small Plate: | ||
| L=31mm W=34mm, H=12mm | Large Plate: | |
| L=35mm, W=38mm, H=18mm | ||
| Small Plate: | ||
| L=31mm, W=34mm, H=10mm | ||
| Screw Holes | · For 1.2 mm, 1.4 mm and 1.7 mm | |
| screws | ||
| · Number of screw holes along rim: 4 | ||
| · Two screw fixation arms with a | ||
| number of 2 screw holes each | ||
| · Position of screw fixation arms at | ||
| 1st and 3rd screw hole from medial | · For 1.5 mm and 1.8 mm screws | |
| · Number of screw holes along rim: 4 | ||
| · Two screw fixation arms with a number of 2 | ||
| screw holes each | ||
| · Position of screw fixation arms at 1st and 2nd | ||
| screw hole from medial |
Traditional 510(k)
4
The Subject Device is made of biocompatible commercially pure titanium (CP Ti Grade 2); the Predicate is made of pure titanium.
The Subject Device is pre-bent in a 3D shape and size similar to the Predicate Device.
D: Packaging
Table 4: Technological Characteristics of Packaging
| | IN AN ANNA EN A FRIEND A BE LEAR A SECURITIE E LE PROVECE IN LE FRIENDE E LE FRUITE LE FREE LE LE LEVEL
Ipvice
Iniant ' |
Tedicate
Device | |
|----------------|-------------------------------------------------------------------------------------------------------------------------------|------------------------|--|
| Packaging
2 | Non-sterile | sterile
· STATIC · | |
The Subject Device is delivered non-sterile. The Predicate Device is delivered nonsterile and sterile.
Substantial Equivalence Conclusion:
The Stryker Universal Orbital Floor System has similar material and technological characteristics, and the same principal of operation as the Predicate Device. The intended use and indications for use are nearly identical to the Predicate Device.
5
Image /page/5/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus, a symbol often associated with medicine and healthcare, with three wave-like lines representing the flow of health and well-being. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the caduceus, indicating the department's name and national affiliation.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 9, 2013
Mr. Jamshed Badarpura Regulatory Compliance Analyst Stryker 750 Trade Center Way PORTAGE MI 49002
Re: K123786
Trade/Device Name: Stryker Universal Orbital Floor System Regulation Number: 21 CFR 872.4760 Regulation Name: Bone Plate Regulatory Class: II Product Code: JEY Dated: March 4, 2013 Received: March 7, 2013
Dear Mr. Badarpura:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
6
Page 2 - Mr. Badarpura
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Image /page/6/Figure/6 description: The image shows the name "Kwame O. Ulmer" in bold, black font at the top. Below the name is a faded logo that appears to be for the FDA. To the right of the logo, the word "for" is written in a smaller, plain font.
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
Indications for Use
510(k) Number (if known):
K123786
Device Name:
Indications For Use:
Stryker Universal Orbital Floor System
The Stryker Universal Orbital Floor System is intended to be used in the reconstruction of the floor and/or medial wall of the orbit.
The Stryker Universal Orbital Floor System is indicated for the reconstructive treatment of orbital floor and/or medial wall trauma or bone excision in adult patients.
× Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary S. Runner -S ﺎ 2013:04.05 And DA ﺍﻟﻤﺴﺎﻋﺪﺓ 11 12:24:33 -04'00'
(Division Sign-Off) (Division Sign-On)
Division of Anesthesiology, General Hospital Division Control, Dental Devices
123786
Page 1 of _ 1
510(k) Number;_